An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC
NCT06083870
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer Metastatic
Interventions
DRUG:
Oba01
Sponsor
Lu Shun